Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Effect of roflumilast on exacerbation rate in patients with COPD. A 52 week, double-blind study with 500 mcg roflumilast once daily versus placebo.


Collapse Overview 
Collapse sponsor award id
BY217 M2-125


Collapse Biography 

Collapse Time 
Collapse start date
2007-01-04

Collapse end date
2009-01-04